gentamicin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

gentamicin has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akthar, AS; Elmore, CJ; Silswal, N; Srinivas, S; Swan, HK; Tchikrizov, V; Touchberry, CD; Wacker, MJ; Wetmore, LA1

Other Studies

1 other study(ies) available for gentamicin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB.
    BMC pharmacology & toxicology, 2014, Dec-17, Volume: 15

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Boron Compounds; Cardiomegaly; Cell Death; Cell Line; Cells, Cultured; Gentamicins; Male; Mice; Muscle Proteins; Myocardium; Myocytes, Cardiac; Receptors, Thromboxane A2, Prostaglandin H2; RNA, Messenger

2014